• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK IRELAND LTD EVOLUTION® ESOPHAGEAL CONTROLLED-RELEASE STENT - FULLY COVERED; ESW PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK IRELAND LTD EVOLUTION® ESOPHAGEAL CONTROLLED-RELEASE STENT - FULLY COVERED; ESW PROSTHESIS, ESOPHAGEAL Back to Search Results
Catalog Number EVO-FC-R-20-25-8-E
Device Problem Migration (4003)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  Injury  
Manufacturer Narrative
Investigation is still pending, a follow-up mdr report will be submitted to include the investigation conclusions.
 
Event Description
Mdr- 2054 301-032 ae1 -device issues: stent migration, relationship: device; not related, procedure; not relation, pre-existing; no, deficiency: no.Distal stent migration to stomach - endoscopic stent removal.Patient outcome: event: resolved ( patient recovered / stabilized), treatment: endoscopic; study stent removed, death: no.
 
Manufacturer Narrative
Device evaluation: the device evaluation for evo-fc-r-20-25-8-e of lot c1698036 could not be completed as the device or photographic evidence of the device was not returned for evaluation.Manufacturing records: prior to distribution all devices are subjected to a visual inspection and functional inspection to ensure device integrity.A review of the manufacturing records of lot c1698036 did not reveal any discrepancies that could have contributed to this complaint issue.Review historical data: the review of relevant manufacturing records of lot number c1698036 confirms the failure mode has not previously occurred for this work order.Instructions for use and/label: the instructions for use, ifu0067 which accompanies this device, states ¿after stent placement, alternative methods of treatment such as chemotherapy and tumour shrinkage should not be administered this may increase risk of stent migration due to tumour shrinkage, stent erosion, and/or mucosal bleeding.¿¿ there is no evidence to suggest that the customer did not follow the instructions for use.Image review: an image was not returned for evaluation.Root cause analysis: definitive root cause could not be determined.A possible root cause could be attributed to patient condition as per instructions for use, stent migration is listed as a potential complication following the placement of this device.Confirmation of complaint: complaint is confirmed based on customer and/or rep testimony.Corrective action/ correction: complaints of this nature will continue to be monitored for potential emerging trends.Summary of investigation: according to the customer the stent migrated to the stomach 30 days post stent placement.Confirmed quantity of 1 device, confirmed used.According to the initial report, the stent was removed endoscopically.Investigation findings conclude a definitive root cause was not established.A possible root cause could be attributed to patient condition.
 
Event Description
Supplemental report is being submitted due to the completion of the investigation on 17-nov-2023.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUTION® ESOPHAGEAL CONTROLLED-RELEASE STENT - FULLY COVERED
Type of Device
ESW PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
COOK IRELAND LTD
o halloran road
limerick
Manufacturer (Section G)
COOK IRELAND LTD
o halloran road
national technology park
limerick
Manufacturer Contact
sinead o'leary
o halloran road
national technology park
limerick 
MDR Report Key16830472
MDR Text Key314159245
Report Number3001845648-2023-00273
Device Sequence Number1
Product Code ESW
UDI-Device Identifier10827002551708
UDI-Public(01)10827002551708(17)220113(10)C1698036
Combination Product (y/n)N
PMA/PMN Number
K093619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/13/2022
Device Catalogue NumberEVO-FC-R-20-25-8-E
Device Lot NumberC1698036
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Event Location Hospital
Initial Date Manufacturer Received 04/07/2023
Initial Date FDA Received04/28/2023
Supplement Dates Manufacturer Received04/07/2023
Supplement Dates FDA Received12/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient SexFemale
Patient Weight69 KG
-
-